Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Vivos Therapeutics Inc
VVOS
Healthcare
Medical Devices
Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and...
snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. The company was formerly known as Vivos BioTechnologies, Inc. and changed its name to Vivos Therapeutics, Inc. in March 2018. The company was founded in 2016 and is based in Littleton, Colorado.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:VVOS)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 08, 2024 7:30am
New Press Release - Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association
New Medical Codes will Facilitate Billing by Commercial Payers for Vivos CARE Treatment for Obstructive Sleep Apnea in Adults and Children LITTLETON, Colo., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology company...
read article.
(1441)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 19, 2024 10:53am
VVOS......I'll say it another time ; )
You've all been had ........ AGAIN !!!!!!!!!!!!!!!!!!!!!!
CSE:SKUR Appoints Retired CIA Senior Intelligence Service Expert John T. Lewis as CTO & Strategic Advisor
posted Apr 20, 2026 9:00am by
Sekur Private Data Ltd.
-
|
Throughout his CIA career, Mr. Lewis was at the forefront of developing secure systems and communications capabilities that operated in the world's most hostile environments. From hands-on engineering of clandestine RF systems to helping lead the CIA's Federal Laboratory and shaping Intelligence Community-wide research strategy, his career was defined by one constant: ensuring that sensitive information and communications remain protected against the most sophisticated adversaries on earth. ...read more
(1441)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 19, 2024 10:51am
RE:VVOS.....Early a.m runner on NR
And you thought I was just joking????? Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
...more
(1441)
•••
Iseneschal
X
Comment by
Iseneschal
on Sep 18, 2024 11:26am
RE:VVOS....Crash Boom Bang....now at the opening price
It rallied....albeit.....briefly.......Now back to where it could just completely tank . JMHO....currently at $3.56
(1441)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 18, 2024 10:21am
VVOS....Crash Boom Bang....now at the opening price
Better rally from here or it's all over but the crying $3.45
(1441)
•••
Iseneschal
X
Post by
Iseneschal
on Sep 18, 2024 9:28am
VVOS.....Early a.m runner on NR
You might think the volume & price action is related to this a.m's NR..... Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea
...more
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 3:00am
Vivos Therapeutics, Inc. (NASDAQ:VVOS): Innovative Sleep Apn
https://beyondspx.com/2024/08/02/vivos-therapeutics-inc-nasdaqvvos-innovative-sleep-apnea-treatment-poised-for-significant-growth/
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Grizzly Sampling & Fieldwork Results in Three New Gold-Copper-Silver Discoveries at BC Critical Minerals & Precious Metals Project
A junior mining company focused on revitalizing North America's tungsten supply
This Bitcoin-first microcap is using its balance sheet to accumulate BTC
Podcasts